Creative Biolabs Webinar to Address T Cell Dysfunction in Tumor Microenvironments

Creative Biolabs, a biotechnology service provider specializing in immuno-oncology, has announced an upcoming webinar titled "Modeling T Cell Dysfunction in Tumor Microenvironments." Scheduled for September 1, 2026, at 10:00 AM EDT, the live virtual event will feature a keynote presentation by Greg M. Delgoffe, Ph.D., Professor of Immunology at the University of Pittsburgh and Director of the Tumor Microenvironment Center at the UPMC Hillman Cancer Center.

The tumor microenvironment (TME) is a complex ecosystem where cancer cells, immune cells, and metabolites interact. As tumors progress, they create a metabolically challenging environment characterized by nutrient depletion and immunosuppressive byproducts. These conditions impair immune cell function, leading to T cell dysfunction, immune evasion, and reduced responses to standard immunotherapies. Understanding these mechanisms is critical for developing effective cancer treatments.

During the webinar, Dr. Delgoffe will discuss innovative approaches to modeling the TME. Traditional models often fail to capture the nuanced interactions between tumor metabolism and immune regulation. By utilizing advanced preclinical testing services and robust in vivo and in vitro models, researchers can better replicate metabolic stress conditions. These systems provide valuable tools to investigate immune suppression and therapeutic responses under physiologically relevant conditions.

"Understanding how metabolic conditions within tumors influence immune-cell behavior is increasingly important in immuno-oncology," said a senior scientific director at Creative Biolabs. "Dr. Delgoffe's work provides an important perspective on how researchers can model these conditions and investigate target discovery and validation."

Webinar highlights include: how tumor metabolic environments contribute to immune suppression and T cell exhaustion; strategies for modeling TME conditions in preclinical research systems; the mechanisms underlying T cell exhaustion and how nutrient depletion influences T cell function; and how immunometabolism insights can guide therapeutic strategies to enhance cancer immunotherapy.

This webinar is especially relevant for cancer immunology researchers, pharmaceutical and biotechnology professionals, and R&D teams dedicated to oncology drug discovery. For webinar details and registration, visit the registration page.